| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.8 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.0083 | 0.9 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.031 | 0.9 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.0092 | 0.9 |